These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2929768

  • 1. Cyproheptadine in movement disorders.
    Bacher NM, Lewis HA, Field PB.
    Am J Psychiatry; 1989 Apr; 146(4):557-8. PubMed ID: 2929768
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of phenothiazine-induced dyskinesia.
    Goldman D.
    Psychopharmacol Bull; 1976 Apr; 12(2):7, 10. PubMed ID: 3820
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of phenothiazine-induced dyskinesia.
    Goldman D.
    Psychopharmacology (Berl); 1976 Jun 23; 47(3):271-2. PubMed ID: 9653
    [Abstract] [Full Text] [Related]

  • 4. [Shy-Drager disease. Hemodynamic and pharmacodynamic studies. Value of cyproheptadine].
    Mahoudeau D, Singer B, Gilbert JC, Goulon M, Gajdos P.
    Rev Neurol (Paris); 1972 Jun 23; 126(6):401-14. PubMed ID: 4667507
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of phenothiazine drug intoxication with benztropine.
    Bellman MH.
    Arch Dis Child; 1974 Aug 23; 49(8):664-5. PubMed ID: 4424791
    [No Abstract] [Full Text] [Related]

  • 6. A middle ground in prophylactic antiparkinsonian medication.
    Huttenbach DE.
    Am J Psychiatry; 1977 Jul 23; 134(7):820-1. PubMed ID: 17309
    [No Abstract] [Full Text] [Related]

  • 7. Letter: Involuntary facial movements.
    Walsh CH.
    Br Med J; 1975 Mar 29; 1(5960):737. PubMed ID: 1125690
    [No Abstract] [Full Text] [Related]

  • 8. [Study of the effect of certain pharmacological agents on tardive dyskinesias and the rabbit syndrome].
    Jus K, Jus A, Gautier J, Villeneuve A, Pires P, Pineau R, Villeneuve R.
    Vie Med Can Fr; 1973 Sep 29; 2(9):871-5. PubMed ID: 4761483
    [No Abstract] [Full Text] [Related]

  • 9. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM, Schmitt PP.
    Curr Ther Res Clin Exp; 1973 Aug 29; 15(8):552-8. PubMed ID: 4200529
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome.
    Jus K, Jus A, Gautier J, Villeneuve A, Pires P, Pineau R, Villeneuv R.
    Int J Clin Pharmacol; 1974 Mar 29; 9(2):138-45. PubMed ID: 4827556
    [No Abstract] [Full Text] [Related]

  • 11. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May 29; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 12. Polygraphic profile of oral tardive dyskinesia and of rabbit syndrome: for quantitative and qualitative evaluation.
    Jus K, Jus A, Villeneuve A.
    Dis Nerv Syst; 1973 Jan 29; 34(1):27-32. PubMed ID: 4350828
    [No Abstract] [Full Text] [Related]

  • 13. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL.
    Dis Nerv Syst; 1976 Apr 29; 37(4):219-24. PubMed ID: 1253676
    [No Abstract] [Full Text] [Related]

  • 14. Prolonged metoclopramide-induced dyskinetic reaction.
    Leopold NA.
    Neurology; 1984 Feb 29; 34(2):238-9. PubMed ID: 6538018
    [Abstract] [Full Text] [Related]

  • 15. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R, Van Lommel R, Baro F.
    Acta Psychiatr Scand; 1971 Feb 29; 47(4):399-410. PubMed ID: 4947805
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacology of blepharospasm-oromandibular dystonia syndrome.
    Casey DE.
    Neurology; 1980 Jul 29; 30(7 Pt 1):690-5. PubMed ID: 7190236
    [Abstract] [Full Text] [Related]

  • 17. Side effects of depot fluphenazines.
    Ayd FJ.
    Adv Biochem Psychopharmacol; 1974 Jul 29; 9(0):301-9. PubMed ID: 4599435
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of valproate tremors.
    Karas BJ, Wilder BJ, Hammond EJ, Bauman AW.
    Neurology; 1983 Oct 29; 33(10):1380-2. PubMed ID: 6412157
    [Abstract] [Full Text] [Related]

  • 19. Thrombocytopenia possibly associated with olanzapine and subsequently with benztropine mesylate.
    Bogunovic O, Viswanathan R.
    Psychosomatics; 2000 Oct 29; 41(3):277-8. PubMed ID: 10849461
    [No Abstract] [Full Text] [Related]

  • 20. Relief of benign essential blepharospasm and ? memory loss by cyproheptadine.
    Fasanella RM.
    Conn Med; 1993 Aug 29; 57(8):565-6. PubMed ID: 8243089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.